Donald A Bergstrom

President, R&D

Donald A Bergstrom (President, R&D) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Relay Therapeutics, Inc. (RLAY). The largest single filing was $1.6M of RLAY (93,456 sh × $16.94, as filed), executed Jun 22.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 5 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$2.3M

shares × price, as filed

Last traded

Sep 8

Filed Sep 9

Median ADV $74.0M across their filed names

Open performance→

Volume by month

Buys $0 Sells $2.6M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 5 filings

Sector per market data · by filing · past 12 months

Most traded names

RLAY

Relay Therapeutics, Inc. RLAY · 0 buys · 6 sells 6 filings

Recent filings

RLAYSALE Relay Therapeutics, Inc. View filing → $162K
8,530 sh × $18.97
Exec Sep 8
Filed Sep 9 · 4:17 PM ET RLAYSALE Relay Therapeutics, Inc. View filing → $162K
8,660 sh × $18.71
Exec Jul 6
Filed Jul 8 · 5:11 PM ET RLAYSALE Relay Therapeutics, Inc. View filing → $1.6M
93,456 sh × $16.94
Exec Jun 22
Filed Jun 24 · 5:30 PM ET RLAYSALE Relay Therapeutics, Inc. View filing → $144K
18,895 sh × $7.62
Exec Jan 27
Filed Jan 29 · 5:30 PM ET RLAYSALE Relay Therapeutics, Inc. View filing → $225K
30,897 sh × $7.29
Exec Oct 28 2025
Filed Oct 30 2025 · 5:30 PM ET RLAYSALE Relay Therapeutics, Inc. View filing → $347K
77,230 sh across 2 lots
Exec Jan 29 2025
Filed Jan 30 2025 · 5:30 PM ET